Identifying Heart, Lung, and Blood Disease-Causing Variants

by: TopGovernmentGrants Editorial Staff

The National Institutes of Health, otherwise known as NIH, is the agency operating within the United States Department of Health and Human Services that is fundamentally responsible for all of the country's biomedical and health-related research studies.

The programs and objectives of the NIH are tailored to contribute to the achievement of their agency mission, which is to "seek fundamental knowledge about the nature and behavior of living systems and the application of that knowledge to enhance health, lengthen life, and reduce the burdens of illness and disability."

In keeping with this mission, the National Institutes of Health has formed a partnership with the National Heart, Lung, and Blood Institute to establish a program that aims to Identify Heart, Lung, and Blood Disease-Causing Variants.

The Identifying Heart, Lung, and Blood Disease-Causing Variants Program aims to follow suit to research studies that intend to identify heart, lung, and blood disease-causing rare or lower frequency variants through the use of the extensive exome data that was discovered under the Recovery and Reinvestment Act of 2009.

The organizers of the program believe that this data will enable lung, heart and blood investigators, to focus on variants, genes, and pathways that could potentially lead them to a deeper and more thorough understanding of certain complex diseases.

  (continued...)

Identifying Heart, Lung, and Blood Disease-Causing Variants
  Page 2

About The Author The TopGovernmentGrants Editorial Staff maintains one the most comprehensive Websites offering information on government grants and federal government programs. The staff also provides resources to other Websites with information on environmental grants and grants for youth programs.

Additional Resources

category - Health Grants

Pilot Studies of Innovative Treatments in Mental Disorders Project
The National Institutes of Health has recently collaborated with the National Institutes of Mental Health (NIMH) to establish the Pilot Studies of Innovative Treatments in Mental Disorders Program.

---

Grand Challenges in Global Mental Health: Integrating Mental Health into Chronic Disease Care Provision in Low- and Middle-Income Countries
The National Institutes of Health has recently formed a partnership with the National Institute of Mental Health (NIMH) in order to establish the Grand Challenges in Global Mental Health: Integrating Mental Health into Chronic Disease Care Provision in Low- and Middle-Income Countries Program.

---

2012 Tuberous Sclerosis Complex Clinical Trial Award Program
In line with this mission, the United States Department of Defense has recently established the 2012 Tuberous Sclerosis Complex Clinical Trial Award Program in an attempt to financially support the studies regarding the promotion innovative research focused on decreasing the clinical impact of tuberous sclerosis complex (TSC).

---

Predictive Lung Deposition Models for Safety and Efficacy of Orally Inhaled Drug Products Program.
The USFA has recently formed a collaboration with the National Institutes of Health to establish the Predictive Lung Deposition Models for Safety and Efficacy of Orally Inhaled Drug Products Program.

---